Cargando…

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases

Circular RNAs (circRNA) are involved in a variety of human heart diseases, however, circRNA expression profiles and circRNA-miRNA-mRNA regulatory network in human atrial fibrillation (AF) especially with valvular heart diseases (VHD) remain poorly understood. A high-throughput RNA sequencing was use...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiyu, Tang, Xinlong, Chong, Hoshun, Cao, Hailong, Fan, Fudong, Pan, Jun, Wang, Dongjin, Zhou, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714832/ https://www.ncbi.nlm.nih.gov/pubmed/33330659 http://dx.doi.org/10.3389/fcvm.2020.597932

Ejemplares similares

Preoperative monocyte‐to‐HDL‐cholesterol ratio predicts early recurrence after radiofrequency maze procedure of valvular atrial fibrillation
por: Adili, Ailiya, et al.
Publicado: (2020)

Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial
por: Zhang, He, et al.
Publicado: (2022)

Quantitative acetylated proteomics on left atrial appendage tissues revealed atrial energy metabolism and contraction status in patients with valvular heart disease with atrial fibrillation
por: Tu, Tao, et al.
Publicado: (2022)

Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study
por: Gao, Jie, et al.
Publicado: (2022)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
por: Martha, Januar Wibawa, et al.
Publicado: (2021)

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
por: Song, Ziliang, et al.
Publicado: (2020)

Nomogram to Predict Left Atrial Thrombus or Spontaneous Echo Contrast in Patients With Non-valvular Atrial Fibrillation
por: Li, Zhitong, et al.
Publicado: (2021)

Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China
por: Shi, Shaobo, et al.
Publicado: (2022)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2021)

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
por: Liu, Ya-ou, et al.
Publicado: (2022)

Analysis of risk factors for postoperative mortality in acute type A aortic dissection patients under different critical levels
por: Zhu, Xiyu, et al.
Publicado: (2023)

Incidence of atrial functional tricuspid regurgitation and its correlation with tricuspid valvular deformation in patients with persistent atrial fibrillation
por: Yamamoto, Yuko, et al.
Publicado: (2022)

The value of left atrial longitudinal strain in evaluating left atrial appendage spontaneous echo contrast in non-valvular atrial fibrillation
por: Ma, Chang sheng, et al.
Publicado: (2023)

Atrial Fibrillation Underlies Cardiomyocyte Senescence and Contributes to Deleterious Atrial Remodeling during Disease Progression
por: Adili, Ailiya, et al.
Publicado: (2022)

Left atrial epicardial adipose tissue is associated with low voltage zones in the left atrium in patients with non-valvular atrial fibrillation
por: Shao, Yameng, et al.
Publicado: (2022)

Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation
por: Wang, Hua, et al.
Publicado: (2022)

Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Bitar, Yasmin de Souza Lima, et al.
Publicado: (2021)

Prediction of Recurrent Atrial Tachyarrhythmia After Receiving Atrial Flutter Ablation in Patients With Prior Cardiac Surgery for Valvular Heart Disease
por: Chou, Ching-Yao, et al.
Publicado: (2021)

Late outcome of surgical radiofrequency ablation for persistent valvular atrial fibrillation in China: a single-center study
por: Cao, Hailong, et al.
Publicado: (2017)

A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk
por: Liu, Peng-Hui, et al.
Publicado: (2022)

Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK
por: Marciniak, Anna, et al.
Publicado: (2017)

Efficacy and safety evaluation of rivaroxaban vs. warfarin among non-valvular atrial fibrillation patients undergoing lower extremity revascularization
por: Yu, Qingyuan, et al.
Publicado: (2022)

Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis
por: Yang, Zhenzhen, et al.
Publicado: (2023)

A machine learning approach for predicting descending thoracic aortic diameter
por: Yu, Ronghuang, et al.
Publicado: (2023)

Comparative analysis of left atrial appendage closure efficacy and outcomes by CHA(2)DS(2)-VASc score group in patients with non-valvular atrial fibrillation
por: Zhao, Mingzhong, et al.
Publicado: (2022)

Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure
por: Liu, Chang, et al.
Publicado: (2021)

Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Editorial: Multimodality Imaging in Valvular Heart Disease
por: Treibel, Thomas A., et al.
Publicado: (2021)

Machine learning-based analysis of risk factors for atrial fibrillation recurrence after Cox-Maze IV procedure in patients with atrial fibrillation and chronic valvular disease: A retrospective cohort study with a control group
por: Jiang, Zenan, et al.
Publicado: (2023)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Effect of Preablation Glycemic Control on Outcomes of Atrial Fibrillation Patients With Diabetes Mellitus Following Valvular Surgery Combined With the Cox-Maze IV Procedure
por: Peng, Zhan, et al.
Publicado: (2022)

The safety and efficacy of direct oral anticoagulants among chronic kidney disease patients on dialysis with non-valvular atrial fibrillation: a meta-analysis
por: Mapili, Jerahmeel Aleson L., et al.
Publicado: (2023)

Editorial: Inflammation, Metabolism and Epigenetics in Valvular Heart Disease
por: Jover, Eva, et al.
Publicado: (2022)

Cardiac Computed Tomography: Application in Valvular Heart Disease
por: Patel, Kush P., et al.
Publicado: (2022)

Editorial: Multimodality imaging in the evaluation of valvular heart disease
por: Morris, Daniel A., et al.
Publicado: (2022)

Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
por: Johnson, Michelle E, et al.
Publicado: (2016)

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry
por: Camm, A John, et al.
Publicado: (2017)

Impact of severe valvular heart disease in adult congenital heart disease patients
por: Graziani, Francesca, et al.
Publicado: (2022)

Different heart failure phenotypes of valvular heart disease: the role of mitochondrial dysfunction
por: Zhang, Shenghui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jhanukva90uiu6v0mfira5tmov